Zimmer Biomet Holdings, Inc. (ZBH) Competitors & Peers
The 5 largest companies in the same industry as Zimmer Biomet Holdings, Inc., by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| ABT | Peer | $101.29 | P/E 32.7RSI 36Cap 175.3 B |
| SYK | Competitor | $272.36 | P/E 28.3RSI 32Cap 104.5 B |
| MDT | Competitor | $88.64 | P/E 21.7RSI 38Cap 112.5 B |
| BSX | Peer | $43.92 | P/E 17.8RSI 42Cap 63.7 B |
| EW | Peer | $86.29 | P/E 52.5RSI 49Cap 50.8 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Confirmed relationships (cited)
Sourced from a public filing or disclosure — each links to its origin.
- SYKCompetitor
Zimmer Biomet and Stryker are the two leading competitors in the large joint orthopedic reconstruction market (hip and knee implants), where Zimmer's ROSA platform competes directly with Stryker's Mako platform.
Confirmed — SEC filing / public disclosuresec.gov ↗ - MDTCompetitor
Zimmer Biomet competes with Medtronic in spine implants and surgical navigation/robotics, where ZBH's ROSA spine system competes with Medtronic's Mazor and Hugo platforms.
Confirmed — SEC filing / public disclosuresec.gov ↗ - JNJCompetitor
Zimmer Biomet competes with Johnson & Johnson's orthopedics franchise (DePuy Synthes) in hip, knee, trauma, and extremity implants.
Confirmed — SEC filing / public disclosuresec.gov ↗ - SNNCompetitor
Zimmer Biomet competes with Smith & Nephew in reconstructive orthopedic devices, sports medicine, and surgical robotics (SNN's CORI system).
Confirmed — SEC filing / public disclosuresec.gov ↗
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- FNAPartner
Zimmer Biomet completed the acquisition of Paragon 28 in April 2025 for approximately $1.1 billion in equity value to expand its footprint in the foot and ankle orthopedic market.
Model-inferred, unverified — treat as a lead, not evidence - AAPLPartner
Zimmer Biomet's mymobility digital care management platform is built in partnership with Apple, integrating with Apple Watch and Apple Health to monitor patient recovery after joint replacement surgery.
Model-inferred, unverified — treat as a lead, not evidence - ORTHOGRIDPartner
Zimmer Biomet entered a co-marketing agreement with OrthoGrid Systems to integrate OrthoGrid Hip AI navigation software with Zimmer Biomet's direct anterior hip replacement solutions.
Model-inferred, unverified — treat as a lead, not evidence - CAHSupplier
Cardinal Health is one of Zimmer Biomet's primary wholesale distributors, purchasing orthopedic surgical instruments, supplies, and wound care products for distribution to hospitals.
Model-inferred, unverified — treat as a lead, not evidence - CORSupplier
Cencora (formerly AmerisourceBergen) acts as a distributor of Zimmer Biomet's orthopedic and medical products to institutional healthcare providers.
Model-inferred, unverified — treat as a lead, not evidence - MCKSupplier
McKesson distributes Zimmer Biomet's medical equipment, accessories, and orthopaedic products to surgical centers and hospitals across North America.
Model-inferred, unverified — treat as a lead, not evidence - ENOVCompetitor
Zimmer Biomet competes with Enovis (formerly Colfax/DJO Global) in orthopedic reconstructive implants, braces, and rehabilitation products.
Model-inferred, unverified — treat as a lead, not evidence